TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Phase 2a Randomized Placebo-Controlled Human Challenge Trial of the Respiratory Syncytial Virus L-Protein Inhibitor S-337395 for Respiratory Syncytial Virus Infection.

Stuart Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.